MRI more effective at detecting recurrent breast cancer
the ONA take:
According to a new study published in the journal Radiology, single-screening magnetic resonance imaging (MRI) better detected recurrent breast cancer in women who had undergone breast conserving therapy (BCT) and previously had negative mammography and ultrasonographic (US) findings.
Hye Mi Gweon, MD, of the department of radiology at the Seoul National University College of Medicine in Seoul, South Korea, and colleagues found that single-screening MRI detected 18.1 additional cancers per 1000 women with a history of BCT.
The team identified 607 women with a median age of 48 between 2008 and 2012. All women underwent BCT for breast cancer, had negative mammography and US findings, and underwent a subsequent MRI. Screening with MRI detected eleven additional cancers, eight of which were invasive and three were ductal carcinoma in situ.
According to multivariate analysis, women who benefited from subsequent MRI screening were younger than 50 years old at the time of initial diagnosis and if there was a 24-month interval between initial surgery to eradicate the cancer and MRI screening. The investigators suggest that women with a history of breast cancer who underwent BCT would be the most appropriate candidates for MRI screening due to the high detection of T1 invasive cancers.
MRI detects 18.1 additional cancers after negative findings.
These women had negative mammography and US findings, and most underwent preoperative MRI examinations (91.8 percent).
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|